Cargando…
Fondaparinux in heparin‐induced thrombocytopenia: A decade's worth of clinical experience
Autor principal: | Schindewolf, Marc |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6332747/ https://www.ncbi.nlm.nih.gov/pubmed/30656269 http://dx.doi.org/10.1002/rth2.12169 |
Ejemplares similares
-
The Fondaparinux Paradox: Fondaparinux-Related Heparin-induced Thrombocytopenia
por: Vadi, Sonali, et al.
Publicado: (2018) -
Failure of Fondaparinux in Autoimmune Heparin-Induced Thrombocytopenia
por: Sartori, Michelangelo, et al.
Publicado: (2020) -
Fondaparinux: another potential treatment for heparin-induced thrombocytopenia type II?
por: Honore, Patrick M., et al.
Publicado: (2016) -
Use of fondaparinux in a pregnant woman with pulmonary embolism and heparin-induced thrombocytopenia
por: Ciurzyński, Michał, et al.
Publicado: (2011) -
Systematic review of fondaparinux for heparin‐induced thrombocytopenia: When there are no randomized controlled trials
por: Linkins, Lori‐Ann, et al.
Publicado: (2018)